Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
8081
Spatial MTPM for the CCD of EEC and RPH.
Published 2024“…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …”
-
8082
Influencing factors of CCD.
Published 2024“…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …”
-
8083
Kernel density estimation of the CCD.
Published 2024“…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …”
-
8084
National and regional results of CCD.
Published 2024“…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …”
-
8085
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis − correlation between neurofilament light chain and nerve conduction study
Published 2024“…NfL levels significantly decreased with patisiran, although no significant changes were observed in CMAP and SNAP.…”
-
8086
Data Sheet 1_Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis.pdf
Published 2025“…There was no significant difference in the risk of AF/AFL between the high-dose SGLT2 inhibitors group and the low-dose SGLT2 inhibitors group (RR 0.78; 95%CI, 0.60–1.02; I<sup>2</sup> = 0%; P = 0.07), although a decreasing trend in the high-dose group was noted. …”
-
8087
Analysis of differential microbiome and classification prediction model between case and control groups.
Published 2025“…<p><b>(A)</b> Linear discriminant analysis [LDA; (log10)>2] and (B) effect size (LEfSe) analysis revealed significant differences (P < 0.01) in the microbiota of the case (orange, negative score) and control groups (blue, positive score) groups. …”
-
8088
Surgical changes through ISIW implantation.
Published 2025“…Pre- and postoperative data are compared by Tukey’s HSD test and asterisks mean statistical significance (p < 0.05). IOP decreases significantly from 3 to 12 months after surgery whereas GMS decreases from one day to 12 months after surgery. …”
-
8089
The <i>ENT2</i> knockout effects on CRC proliferation and survival.
Published 2025“…Plating Efficiency (PE) was calculated as the ratio of the number of colonies to the number of cells seeded. PE decreased significantly in both HKO1 and HKO2. No significant difference occurred between NTC and DKO cells. …”
-
8090
Data Sheet 1_Phyllotaxy and environmental factors influences on leaf trait dimensions in Fraxinus mandshurica: a multidimensional approach within temperate forests.docx
Published 2025“…</p>Results<p>We found that (1) specific leaf area and leaf nitrogen concentration significantly increase along the phyllotaxy gradient (from phyllotaxy 1 to 6), while leaf dry matter content, leaf thickness, and stomatal density significantly decrease. …”
-
8091
Search strategy.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8092
Fig 1 -
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8093
GMT by age cohort for PWH and PWoH.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8094
Fig 4 -
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8095
Difference in GMT for HPV16 and HPV18 in PWH.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8096
Fig 3 -
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8097
Summary of characteristics of studies reviewed.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8098
Cumulative meta-analysis.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8099
Summary of immunogenicity information.
Published 2024“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”
-
8100
Fig 5 -
Published 2024“…Among the three RpoD binding sites upstream of <i>cyoABCDE</i>, only the binding intensity at the site corresponding to the transcription start site (TSS) significantly decreases. Additionally, a significant reduction in RpoD binding is also observed for <i>atpIBEFHAGDC</i>. …”